{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:10:35Z","timestamp":1762521035128},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Autonomic Research"],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1007\/bf02291355","type":"journal-article","created":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T15:59:53Z","timestamp":1138204793000},"page":"193-196","source":"Crossref","is-referenced-by-count":14,"title":["The use of clonidine in the management of autonomic overactivity in neuroleptic malignant syndrome"],"prefix":"10.1007","volume":"10","author":[{"given":"Leonidas","family":"Gregorakos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Thomaides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stamatina","family":"Stratouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterini","family":"Sakayanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02291355_CR1","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1176\/ajp.143.12.1587","volume":"143","author":"G Addoniyio","year":"1986","unstructured":"Addoniyio G, Susman VL, Roth SD. Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients.Am J Psychiatry 1986; 143:1587\u20131590.","journal-title":"Am J Psychiatry"},{"key":"BF02291355_CR2","first-page":"79","volume":"41","author":"SN Caroff","year":"1989","unstructured":"Caroff SN. The neuroleptic malignant syndrome.J Clin Psychiatry 1989; 41:79\u201383.","journal-title":"J Clin Psychiatry"},{"key":"BF02291355_CR3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00000542-198707000-00004","volume":"67","author":"S Caroff","year":"1987","unstructured":"Caroff S, Rosenberg H, Fletcher H, Heiman-Patterson TD, Mann SC. Malignant hyperthermia susceptibility in neuroleptic malignant syndrome.Anesthesiology 1987; 67:20\u201325.","journal-title":"Anesthesiology"},{"key":"BF02291355_CR4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1055\/s-2008-1041226","volume":"11","author":"MA Grunner","year":"1991","unstructured":"Grunner MA, Wooten F. Neuroleptic malignant syndrome or parkinsonism hyperpyrexia syndrome.Semin Neurol 1991; 11:228\u2013235.","journal-title":"Semin Neurol"},{"key":"BF02291355_CR5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1056\/NEJM198507183130306","volume":"313","author":"BH Guze","year":"1985","unstructured":"Guze BH, Baxter LR. Current concepts. Neuroleptic malignant syndrome.N Engl J Med 1985; 313:163\u2013166.","journal-title":"N Engl J Med"},{"key":"BF02291355_CR6","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1176\/ajp.138.8.1115","volume":"138","author":"JH Feibel","year":"1981","unstructured":"Feibel JH, Schiffer RB. Sympathoadrenomedullary hyperactivity in the neuroleptic malignant syndrome: a case report.Am J Psychiatry 1981; 138:1115\u20131116.","journal-title":"Am J Psychiatry"},{"key":"BF02291355_CR7","first-page":"320","volume":"47","author":"M Annseau","year":"1986","unstructured":"Annseau M, Reynolds CF, Kupfer DJ, Poncelet PF, Frank G, Dresse AE, et al. Central dopaminergic and noradrenergic receptor blockade in a patient with neuroleptic malignant syndrome.J Clin Psychiatry 1986; 47:320\u2013321.","journal-title":"J Clin Psychiatry"},{"key":"BF02291355_CR8","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/0028-3908(86)90189-9","volume":"25","author":"JW Hubbard","year":"1986","unstructured":"Hubbard JW, Cox RH, Sanders BJ, Lawler JE. Effects of intracerebroventricular injection of clonidine on condition pressor and adrenergic responses in rats.Neuropharmacology 1986; 25:963\u2013972.","journal-title":"Neuropharmacology"},{"key":"BF02291355_CR9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/cpt1977214375","volume":"21","author":"JL Reid","year":"1977","unstructured":"Reid JL, Wing LMH, Mathias CJ, Frankel HL, Neill E. The central hypotensive effect of clonidine studies on tetraplegic subjects.Clin Pharmacol Ther 1977; 21:375\u2013381.","journal-title":"Clin Pharmacol Ther"},{"key":"BF02291355_CR10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2125.1981.tb01217.x","volume":"12","author":"JL Reid","year":"1981","unstructured":"Reid JL. The clinical pharmacology of clonidine and related central antihypertensive agents.Brit J Clin Pharmacol 1981; 12:295\u2013302.","journal-title":"Brit J Clin Pharmacol"},{"key":"BF02291355_CR11","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1176\/ajp.142.10.1137","volume":"142","author":"JL Levenson","year":"1985","unstructured":"Levenson JL. Neuroleptic malignant syndrome.Am J Psychiatry 1985; 142:1137\u20131145.","journal-title":"Am J Psychiatry"},{"key":"BF02291355_CR12","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0006-3223(92)90037-Z","volume":"32","author":"RJ Gurrera","year":"1992","unstructured":"Gurrera RJ, and Romero JA. Sympathoadrenomedullary activity in the neuroleptic malignant syndrome.Biol Psychiatry 1992; 32: 334\u2013343.","journal-title":"Biol Psychiatry"},{"key":"BF02291355_CR13","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0006-3223(90)90002-J","volume":"27","author":"K Nisijima","year":"1990","unstructured":"Nisijima K, Ishiguro T. Neuroleptic malignant syndrome. A study of CSF monoamine metabolism.Biol Psychiatry 1990; 27:280\u2013288.","journal-title":"Biol Psychiatry"},{"key":"BF02291355_CR14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/jnnp.58.3.271","volume":"58","author":"PF Buckley","year":"1995","unstructured":"Buckley PF, Hutchinson M. Neuroleptic malignant syndrome.J Neurol Neurosurg Psychiatry 1995; 58:271\u2013273.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02291355_CR15","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/clpt.1991.184","volume":"50","author":"D Nierenberg","year":"1991","unstructured":"Nierenberg D, Disch M, Manheimer E, Patterson J, Ross J, Silvestri G, et al. Facilitating prompt diagnosis and treatment of the neuroleptic malignant syndrome.Clin Pharmacol Ther 1991; 50: 580\u2013586.","journal-title":"Clin Pharmacol Ther"},{"key":"BF02291355_CR16","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1176\/ajp.147.10.1358","volume":"147","author":"SJ Kish","year":"1990","unstructured":"Kish SJ, Kleinert R, Minauf M, Gilbert J, Walter GF, Slimovitch C, et al. Brain neurotransmitter changes in three patients who had a fatal hyperthermia syndrome.Am J Psychiatry 1990; 147:1358\u20131363.","journal-title":"Am J Psychiatry"},{"key":"BF02291355_CR17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3928\/0048-5713-19910301-10","volume":"21","author":"SC Mann","year":"1991","unstructured":"Mann SC, Caroff SN, Lazarus A. Pathogenesis of neuroleptic malignant syndrome.Psychiatric Annals 1991; 21:175\u2013180.","journal-title":"Psychiatric Annals"},{"key":"BF02291355_CR18","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1176\/ajp.148.7.880","volume":"148","author":"PE Keck","year":"1991","unstructured":"Keck PE, Pope HG, McElroy SL. Declining frequency of neuroleptic malignant syndrome in a hospital population.Am J Psychiatry 1991; 148:880\u2013882.","journal-title":"Am J Psychiatry"},{"key":"BF02291355_CR19","first-page":"797","volume-title":"The pharmacological basis of therapeutics","author":"P Rudd","year":"1980","unstructured":"Rudd P, Blaske TK. Anti hypertensive agents and the drug therapy of hypertension. In:The pharmacological basis of therapeutics, 6th ed. Goodmann LS, Gilman A, eds. Mac Millan: New York; 1980. pp. 797\u2013799.","edition":"6th ed."},{"key":"BF02291355_CR20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/oxfordjournals.bmb.a070986","volume":"29","author":"R Laverty","year":"1973","unstructured":"Laverty R. An account of the pharmacology of some antihypertensive drugs.Br Med Bull 1973; 29:152\u2013157.","journal-title":"Br Med Bull"}],"container-title":["Clinical Autonomic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02291355.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02291355\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02291355","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T19:02:56Z","timestamp":1557946976000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02291355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["BF02291355"],"URL":"https:\/\/doi.org\/10.1007\/bf02291355","relation":{},"ISSN":["0959-9851","1619-1560"],"issn-type":[{"value":"0959-9851","type":"print"},{"value":"1619-1560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,8]]}}}